About

Aims and scope

Archives of Disease in Childhood is an international peer review journal that aims to keep paediatricians and others up to date with advances in the diagnosis and treatment of childhood diseases as well as advocacy issues such as child protection. It focuses on all aspects of child health and disease from the perinatal period (in the Fetal and Neonatal edition) through to adolescence. ADC includes original research reports, commentaries, reviews of clinical and policy issues, and evidence reports. Areas covered include: community child health, public health, epidemiology, acute paediatrics, advocacy, and ethics
The content of ADC Fetal & Neonatal is endorsed by the Royal College of Paediatrics and Child Health for Continued Professional Development in line with RCPCH CPD guidelines.

Ownership

ADC is co-owned by the Royal College of Paediatrics and Child Health and BMJ Group. For more information please refer to the Affiliations section below.

Editions

The Fetal and Neonatal edition

This bimonthly edition of ADC brings together quality research and reviews in the field of perinatal and neonatal medicine. Original research papers cover fetal and neonatal physiology and clinical practice, genetics, perinatal epidemiology and neurodevelopmental outcomes.

Education and Practice edition

This edition of ADC published six times per year (launched in 2004) aims to assist paediatricians, at all levels in their training, in their ongoing professional development. The edition is supported by the RCPCH but has international appeal. The journal contains the following educational sections :

For more information please read the editorial that appeared in the first issue.

Paediatric and Perinatal Drug Therapy

Four times a year ADC will carry a distinct Paediatric and Perinatal Drug Therapy (PPDT) section publishing original research, reviews, comment and analysis in all areas of paediatric drug therapy. The current editors of PPDT, Imti Choonara, Tony Nunn and Michael Rieder will be the editors of this section.
As well as being published in print and online in ADC the section will be reprinted and sent to all members of the European Society for Developmental Perinatal and Paediatric Pharmacology and the Neonatal and Paediatric Pharmacists Group. All subscribers to ADC will have access to PPDT papers.

Journal Statistics

Time from submission to first decision

28 days

Time from acceptance to publication

18 days (online) 6 months (print)

Frequency

ADC is published monthly FNN and E&P are published bimonthly

Impact Factor

ADC: 3.265 FNN: 3.786 EP: 1.215

Indexed By

Index Medicus (Medline), ISI Current Contents (Web of Science), Excerpta Medica (Embase)

Launch Date

1926

ISSN of ADC

0003-9888

ISSN of ADC Online

1468-2044

ISSN of FNN

1359-2998

ISSN of FNN Online

1468-2052

ISSN of E&P

1743-0585

ISSN of E&P Online

1743-0593

Contact Information

For all contact information please refer to the Contact Us page.

For Authors

Please refer to the Instructions for Authors

Subscriptions

Information on rates and how to subscribe

To advertise

General advertising information for BMJ

Rights and Permissions

Copyright and Permissions Guidelines

Affiliations

Royal College of Paediatrics and Child Health

Members receive print/online access to ADC

Neonatal and Paedatric Pharmacists Group

Members receive ADC with Drug Therapy section

European Society for Developmental Perinatal and Paediatric Pharmacology

Members receive ADC with Drug Therapy section

COPE logo

The BMJ Publishing Group is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

Equator logo

The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.